TVARDI THERAPEUTICS, INC. Temporary Equity, Liquidation Preference
TVARDI THERAPEUTICS, INC. (TVRD) had Temporary Equity, Liquidation Preference of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2026-03-31
- 2025-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2025-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2025-06-30: Temporary Equity, Liquidation Preference $0.00.
- 2024-12-31: Temporary Equity, Liquidation Preference $85.90M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2024-12-31 | $85.90M 10-K · filed 2026-03-31 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-27 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 |
| 2013-12-31 | $65.97M 10-K · filed 2016-03-11 |
| 2012-12-31 | $58.53M 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |